Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
27.37
+1.74 (6.79%)
At close: Aug 25, 2026, 4:00 PM EDT
27.65
+0.28 (1.02%)
After-hours: Aug 25, 2026, 7:30 PM EDT
Apnimed Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 46.89 | 41.89 | 68.35 | 26.55 | 133.83 |
Short-Term Investments | - | - | - | 147.41 | - |
Cash & Short-Term Investments | 46.89 | 41.89 | 68.35 | 173.96 | 133.83 |
Cash Growth | - | -38.71% | -60.71% | 29.99% | - |
Receivables | 0.88 | 0.96 | 1.12 | - | - |
Prepaid Expenses | 0.56 | 0.67 | 0.35 | 0.21 | - |
Other Current Assets | 29.83 | 1.54 | 3.43 | 2.3 | 2.13 |
Total Current Assets | 78.16 | 45.06 | 73.25 | 176.46 | 135.96 |
Property, Plant & Equipment | 0.84 | 0.9 | 1.16 | 0.05 | - |
Long-Term Investments | - | - | - | 37.5 | - |
Other Long-Term Assets | 0.02 | 26.92 | 34.82 | 0.03 | 0.03 |
Total Assets | 79.02 | 72.87 | 109.22 | 214.04 | 135.99 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 3.01 | 1.79 | 3.59 | 4.1 | 0.94 |
Accrued Expenses | 7.21 | 10.94 | 13.4 | 6.05 | 2.24 |
Current Portion of Leases | 0.26 | 0.25 | 0.22 | - | 0.11 |
Current Unearned Revenue | 30.4 | 97.81 | 25 | 10 | - |
Other Current Liabilities | 0.11 | 0.09 | 0.15 | 0.04 | 0.18 |
Total Current Liabilities | 40.99 | 110.88 | 42.36 | 20.19 | 3.47 |
Long-Term Debt | 38.54 | 40.65 | - | - | - |
Long-Term Leases | 0.56 | 0.62 | 0.87 | - | - |
Long-Term Unearned Revenue | - | 15.24 | 45.36 | 65 | - |
Other Long-Term Liabilities | 57.12 | 57.12 | 64.36 | 64.36 | - |
Total Liabilities | 137.2 | 224.51 | 152.95 | 149.54 | 3.47 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 25.51 | 24.56 | 20.54 | 17.45 | 5.23 |
Retained Earnings | -329.63 | -397.34 | -269.15 | -157.85 | -77.6 |
Total Common Equity | -304.12 | -372.78 | -248.62 | -140.39 | -72.37 |
Shareholders' Equity | -58.18 | -151.64 | -43.73 | 64.5 | 132.52 |
Total Liabilities & Equity | 79.02 | 72.87 | 109.22 | 214.04 | 135.99 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 39.35 | 41.52 | 1.1 | - | 0.11 |
Net Cash (Debt) | 7.54 | 0.37 | 67.26 | 173.96 | 133.72 |
Net Cash Growth | - | -99.45% | -61.34% | 30.09% | - |
Net Cash Per Share | 1.39 | 0.07 | 12.52 | 60.35 | 56.31 |
Filing Date Shares Outstanding | 5.64 | 5.42 | 5.38 | 5.35 | 2.37 |
Total Common Shares Outstanding | 5.64 | 5.42 | 5.38 | 5.35 | 2.37 |
Working Capital | 37.17 | -65.82 | 30.89 | 156.28 | 132.49 |
Book Value Per Share | -53.95 | -68.77 | -46.24 | -26.23 | -30.48 |
Tangible Book Value | -304.12 | -372.78 | -248.62 | -140.39 | -72.37 |
Tangible Book Value Per Share | -53.95 | -68.77 | -46.24 | -26.23 | -30.48 |
Machinery | 0.02 | 0.02 | 0.02 | 0.02 | - |
Leasehold Improvements | 0.09 | 0.09 | 0.09 | 0.02 | - |